Oncology and Therapy

Oncol Ther

2366-1070

2366-1089

Therapeutic Area

Genomics, Hematology, Immunology, Internal Medicine, Molecular Medicine, Oncology, Patient Safety, Pharmacoeconomics, Pharmacogenetics & Pharmacogenomics, Pharmacology, Public Health, Toxicology

Caregivers, Clinical Pharmacists, Clinical Pharmacologists, Formulary Managers, Health Scientists, Health Service Researchers, Healthcare Executives, Hematologists, Internists, Oncologists, Patients, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Physicians - Medicine, Policy Makers, Radiation Oncologists, Toxicologists

The journal is of interest to a broad, global audience of pharmaceutical and healthcare professionals from all disciplines of oncology, and publishes original research, reviews, case reports, communications, letters and commentaries on all aspects of oncology and research around solid tumours, haematological malignancies and cancer-related conditions, including, but not limited to: • pre-clinical studies • clinical studies (all phases) • observational (real-world) research • health economics and outcomes research • immunotherapy • biomarkers • pharmacokinetics • pharmacoeconomics • public health • patient-reported outcomes • patient care and management • quality of life. Oncology and Therapy provides an unrivalled rapid- publication journal for authors who want to disseminate their work to a worldwide audience as quickly as possible. Through its 'concierge service' from presubmission to online publication, the journal expedites publication of every article, keeping the authors informed every step of the way. The journal also publishes educational enhanced features.

No associations affiliated with this journal

Adis, part of Springer Nature

Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines